Combo Bundle

Hereditary Cancer Screening

This cancer screening panel looks for genetic changes that increase the risk for many types of cancer. The panel analyzes 48 genes, including the BRCA1 and BRCA2, that are related to hereditary cancer.

Buy now

$49 due now + $249 billed to you by our lab partner after you return your kit.

$49 due today and the rest is billed to your insurance by our lab partner.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Reproductive Carrier Screening

Expanded carrier screening is for those who are pregnant or planning to have a biological child in the future. This test is designed to assess an individual or couple’s risk for having a child with a genetic disease. The panel includes more than 260 diseases, such as Tay-Sachs disease, cystic fibrosis, and sickle cell disease.

Buy now

$49 due now + $249 billed to you by our lab partner after you return your kit.

$49 due today and the rest is billed to your insurance by our lab partner*

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Includes

jscreen’s program fee ($10) includes access to our genetic counselors and care navigators throughout the testing process and following reporting of results

Physician review and test ordering ($59)

At-home saliva collection kit

Virtual care navigation session

Access to jscreen genetic care navigation services

Payment Options

Insurance: $69 due today, the rest billed to your insurance*

Self-pay: $69 today + $498 billed to you after you return your kit.

*Many customers have zero additional cost for their genetic testing, but insurance coverage varies and you may have out of pocket costs depending on your coverage. Our lab partner will email with your cost estimate after they receive your saliva kit, and you may switch to self pay at a future time.

*Insurance coverage varies. You may be required to provide additional payments depending on your coverage. Insurance pre-authorization may be requested to get an estimate of your total out-of-pocket cost before finalizing your order.

*For this bundled pricing your $69 will pay for the ordering provider and jscreen will waive its program fee.

Cart
0

$69.00

Due Today
Please Make sure to select at least one of each product before checking out.

FAQS

Find answers to common questions about the reproductive carrier screen test.

Who Should Take the Test?

The Reproductive Carrier Screen is intended for people who are planning to start or expand their family and wish to know if they are at an increased risk of having a child with a genetic condition.

The Cancer Hereditary Cancer Screen is for anyone who is interested in learning about their inherited risks for cancer can take the test. The likelihood of testing positive is higher for those with a personal and/or family history of cancer, as well as those with Ashkenazi Jewish ancestry.

What is Carrier Screening?

Reproductive carrier screening is testing that helps determine an individual’s or couple’s risk of having a child with a genetic condition. It can provide you, your partner, and your doctor with valuable insights in planning for the health of your future children.

jscreen provides access to a genetic testing panel that screens for over 260 conditions that are inherited in either an autosomal recessive or X-linked pattern.

Autosomal recessive conditions:  When two individuals are carriers for the same recessive disease, there is a 1 in 4 chance in each pregnancy that the baby will be affected with the genetic condition.

X-linked conditions: A child may have symptoms if they inherit the disease-causing gene from only one (typically female) parent.

What is Cancer Screening?

Cancer screening involves tests and procedures to detect cancer in its early stages. It can help identify cancer before symptoms appear, increasing the chances of successful treatment.

What is Jewish Genetic Testing?

Jewish genetic testing is a type of genetic screening that focuses on conditions that are more common in individuals of Ashkenazi Jewish descent. It can help identify potential risks and inform reproductive decisions.

Who should consider taking this test?